SITAGLIPTIN/METFORMIN TEVA 50MG/850 MG TBL FLM 98
Rychlý přehled
| Dosage form | Tablets film-coated |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 634,96 Kč. Maximální cena: 1 844,20 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Monohydrát sitagliptin-hydrochloridu (56,688 mg), sitagliptin (50 mg), metformin-hydrochlorid (850 mg), povidon k 29/32, natrium-lauryl-sulfát, mikrokrystalická celulosa, natrium-stearyl-fumarát, monohydrát laktosy, hyp… |
| Dostupnost / výpadek | The latest report from the manufacturer is from 5. 5. 2025. Výroba je oficiálně zahájena od 28. 4. 2025. |
| Kód SÚKL | 0248487 |
What is the maximum co-payment for SITAGLIPTIN/METFORMIN TEVA?
If the insurance company contributes, the maximum co-payment is 634,96 Kč. The maximum pharmacy price is 1 844,20 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does SITAGLIPTIN/METFORMIN TEVA have a counted co-payment set?
Yes, the medicine has a counted co-payment of 543,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
1 209,24 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe SITAGLIPTIN/METFORMIN TEVA?
Prescription is not conditional on a medical specialization.
What is the composition of SITAGLIPTIN/METFORMIN TEVA?
Monohydrát sitagliptin-hydrochloridu (56,688 mg), sitagliptin (50 mg), metformin-hydrochlorid (850 mg), povidon k 29/32, natrium-lauryl-sulfát, mikrokrystalická celulosa, natrium-stearyl-fumarát, monohydrát laktosy, hypromelosa 2910, oxid titaničitý, triacetin, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to SITAGLIPTIN/METFORMIN TEVA?
The medicine belongs to ATC group A10BD07 – . Medicines with the same active substance can be found here.
Who manufactures SITAGLIPTIN/METFORMIN TEVA?
TEVA PHARMACEUTICALS CR S.R.O., PRAHA (CZ)
Is the medicine in shortage?
The latest report from the manufacturer is from 5. 5. 2025. Production has been officially started as of 28. 4. 2025.
What is the unique code for SITAGLIPTIN/METFORMIN TEVA?
The medicine has code 0248487. Code details can be found here.
How many packs of SITAGLIPTIN/METFORMIN TEVA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of SITAGLIPTIN/METFORMIN TEVA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026